The 37 references in paper L. Dudareva A., M. Batyushin M., Л. Дударева А., М. Батюшин М. (2013) “ХРОНИЧЕСКИЙ ТУБУЛОИНТЕРСТИЦИАЛЬНЫЙ НЕФРИТ, ИНДУЦИРОВАННЫЙ ПРИЁМОМ НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ: ЭПИДЕМИОЛОГИЧЕСКИЕ ОСОБЕННОСТИ И ВОЗМОЖНОСТИ РАННЕЙ ДИАГНОСТИКИ // CHRONICAL TUBULO–INTERSTITSIAL NEPHRITIS INDUCED BY ADMINISTRATION OF NONSTEROID ANTI-INFLAMMATORY DRUGS: EPIDEMIOLOGICAL FEATURES AND POSSIBILITIES OF EARLY DIAGNOSTICS” / spz:neicon:nefr:y:2013:i:5:p:22-26

1
Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gasrointestinal complications. J Rheumatol 1999;(56):18–24
(check this in PDF content)
2
Тареева ИЕ. (ред.) Нефрология: руководство для врачей. Медицина, М., 2000; 68–72
(check this in PDF content)
3
Мухин НА, Тареева ИЕ, Шилов ЕМ. Диагностика и лечение болезней почек. болезней почек. ГЭОТАР-Медиа, М., 2008; 283–324
(check this in PDF content)
4
Шишкин АН. Анальгетическая нефропатия: скрытая угроза. Новые С-Пб врачебн ведом 2003; (2):28–31
(check this in PDF content)
5
Lydford S, McKechnie K, Dougall I. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenousvein: a comparison with the rabbit isolated ear artery. Br J Pharmcol 1996; (117):13–20
(check this in PDF content)
6
Белоусов ЮБ, Грацинская АН. Эффективность и безопасность применения нестероидных противовоспалительных средств: мелоксикам (мовалис). Фарматека 2008;(2):10–15
(check this in PDF content)
7
Dubach UC, Rosner T, Sturner T. An epidemiologic study of abuse of analgesic drags. Effects of phenacetin and salicylate on mortality and cardiovascular morbidity. N Engl J Med 1991;(324):115–160
(check this in PDF content)
8
Арьев АЛ. Тубулоинтерстициальный нефрит в практике интерниста. Новые С-Пб врачебн ведом 2002; (1): 22–26
(check this in PDF content)
9
Winkelmaer WC, Waikar SS, Mogun H et al. Nonselective and cyclooxygenase–2 selective NSAID and acute kidney injury. Am J Med 2008;121[Suppl 12]:1092–1109
(check this in PDF content)
10
Graham MG. Acute renal failure to high –dose celecoxib. Ann Intern Med 2001; (135): 69–70; Alper AB, Meleg–Smith S, Krane NK. Nephrotic syndrome and interstitial nephritis associated with celecoxib. Am J Kidney Dis 2002;(40):1086–1090
(check this in PDF content)
11
Levis SC, Langman ML, Laporte JR et al. Dose–response relationship between individual nonaspirinnonsteroidal anti–inflammatory drags and serious upper gastrointestinal bleeding: a meta –analysis based on individual patient date. Br J Clin Pharmacol 2002;(54):320–326
(check this in PDF content)
12
Komhoff M, Grone HL, Klein Т et al. Localization of cyclooxigenases–1 and–2 in adult and fetal human kidney: implication for renal function. Am J Physiol 1997;(272):460–468
(check this in PDF content)
13
Nasrallah R, Herbert RL. Prosracyclin signaling in the kidney implication for healt and disease. Am J Physiol 2005;(289):235–246
(check this in PDF content)
14
Баринов ЭФ, Сулаева ОН, Лам М.М. Метаболиты арахидоновой кислоты – детерминанты паренхиматозностромальных отношений в почках в норме и при патологии. Нефрология 2006; 10 (3): 14-22
(check this in PDF content)
15
Chang SH, Mathew TH, McDonald SP. Analgesic nephropathy and renal replacement therapy in Australia: trends, comorbidities and outcomes. Clin J Am Soc Nephrol 2008; (3): 768–776
(check this in PDF content)
16
Mihatsch MJ, Khanlari B, Brunner FP. Obituary to analgesic nephropathy–an autopsy study. Nephrol Dial Transplant 2006;21[Suppl 11]:3139–3145
(check this in PDF content)
17
Шеховцева ТГ, Свистун СИ, Долинная НА. Аналгетическая нефропатия. Запорож мед журн 2011;12[Suppl 1]:41–43
(check this in PDF content)
18
Murray MD, Brater DС. Renal toxicity on the non-steroidal anti–inflammatory drags. Annu Rev Pharmacol Toxicol 2008; (33): 435–465
(check this in PDF content)
19
Vriesendorp R. Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs. Clin Nephrol 1986;25[Suppl 2]:105-110
(check this in PDF content)
20
Deegens J, Wetzels J, Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosis. Clin Nephrol 2007; 68 [Suppl 4]: 201-208
(check this in PDF content)
21
Пилотович С. Острый тубуло –интерстициальный нефрит –актуальная проблема нефрологии. Медицина 2001; 4(75):28-32
(check this in PDF content)
22
Махачев БМ, Корсунский АА, Османов ИМ и др. Клиническое значение определения белков в моче для ранней диагностики рефлюкс-нефропатий у детей. Нефрол и диализ 2005;7(1):21—27
(check this in PDF content)
23
Raikou VD. Вeta (2)-Microglobulin, Pulse Pressure and Metabolic Alterations in Hemodialysis Patients. URL:http://www. hemodialysis.com/beta-2 microglobulin_pulse pressure and metabolic alterations in hemodialysis patients.html (дата обращения 9.11.12)
(check this in PDF content)
24
Loghman-Adham M. Renal effects of environmental and occupational lead exposure: a review. Environ Health Perspect 1997;(105):928-938
(check this in PDF content)
25
Muller GA, Zeisberg M, Strutz F. The importance of tubulointerstitial damage in progressive renal disease. Nephrol Dial Transplant 2000;15[Suppl 6]:76–77
(check this in PDF content)
26
Пентюк НО, Пентюк ОО. Взаємозв'язок між нефротоксичністю та фармакокінетикою індометацину та диклофенаку натрію. Ліки 2001;(5):82–85
(check this in PDF content)
27
Hickey EJ, Raje RR, Reid VE et al. Diclofenac induced in vivo nephrotoxicity may involve oxidative stress–mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med 2001:31[Suppl 42]:139–152
(check this in PDF content)
28
Кудин МВ. Ферментурия у детей с нефропатиями из региона с развитой цементной промушленностью. Нефрология 2012;2: 64-66
(check this in PDF content)
29
Дударева ЛА, Батюшин ММ, Цветков ДС. Методы ранней диагностики хронического тубулоинтерстициального нефрита, индуцированного приемом нестероидных противовоспалительных препаратов. Известия вузов СевероКавказский регион 2013;2:89–91
(check this in PDF content)
30
Jang TJ, Kang HJ, Kim JR, Yang CH. Non–steroidal anti– inflammator drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulphide induced gastric cancer cell apoptosis. Carcinogenesis 2004;25[Suppl 10]:1853–1858
(check this in PDF content)
31
Tao Su, LuXia Zhang, XiaoMei Li et al. Regular use of nephrotoxic medications is an independent risk factor for chronic kidney disease—results from a Chinese population study. Nephrol Dial Transplant 2011;26[Suppl 6]:916-1923
(check this in PDF content)
32
Gluhovshi G, Velciov S, Kayca A et al. The effect on proteinuria and urinary NAG of treatment with meloxicam in chronic glomerular disease patients a preliminary study. Int J Clin Pharmacol Ther 2009;47[Suppl 7]:444–453
(check this in PDF content)
33
Herget-Rosenthal S, Poppen D, Husing J et al. Prognostic value of tubular proteinuria and enzymuria to nonoliguric acute tubular necrosis. Clin Chem 2004;(50):552
(check this in PDF content)
34
Zaccaria R, Claudio R. Kidney Disease beyond Nephrology: Intensive care. Nephrol Dial Transplant 2008;(23):1–7
(check this in PDF content)
35
Kocaoğlu S,Karan A, Berkan T, Başdemir G. Acute acetaminophen nephrotoxicity and urinary gamma-glutamyl transferase activity in rats. Drug Metabol Drug Interact 1997;14 [Suppl 7]:47–54
(check this in PDF content)
36
Simeoni U, Schnitzler B, Massfelder T et al. Specific developmental profiles of lysosomal and brush border enzymuria in the human. Biol Neonate 1994;65[Suppl 1]:1–6
(check this in PDF content)
37
Zafirovska KG, Bogdanovska SV, Marina N et al. Urinary excretion of three specific renal tubular enzymes in patients treated with nonsteroidal anti-inflammatory drugs (NSAID). Renal Failure 1993;15[Suppl 1]:51–54 Поступила в редакцию 22.05.2013 г.
(check this in PDF content)